Kohl Medical acquires Livica
SourcingClub was not involved in this transaction.
Kohl Medical acquires 100 percent of the shares in the homecare company Livica from Merzig. Livica specialises in parenteral and enteral nutrition therapy, employs over 200 people and generates revenue of around €40m. Closing is subject to clearance by the Federal Cartel Office and is planned by the end of 2026.
apotheke-adhoc.deHow the deal fits together.
- Publicare (Tochter von Hollister)Seller
Target: Livica
Buyer: Kohl Medical
Who was involved.
- Buyer
- Kohl Medical
- Target
- Livica, Merzig
- Seller
- Publicare (Tochter von Hollister)
- Type
- Strategic
- Sector
- Healthcare & Medtech
- Country
Germany- First reported
- 11/11/2026
- Source
- apotheke-adhoc.de
Deal-Radar no. 46-068 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Method
Valuation in this industry.
4.0 to 9.7times EBITDA
- 4.0x to 6.0xRevenue under €5m
- 6.0x to 7.7x€5m to €50m
- 7.9x to 9.7xover €50m
Market range for Healthcare: Nursing & Care Services, not the price of this deal. Data basis: DUB KMU-Multiples, Q3/2026; preparation: SourcingClub.
Multiples by size class for Healthcare: Nursing & Care Services 12 deals in this industry on the radar
November 2026 on the Deal-Radar.
59 of 139 deals so far are of the type Strategic.
- Strategic59
- Add-on22
- Funding round19
- Carve-out16
- Insolvency10
- Buy-out7
- Minority stake3
- Secondary2
- Merger1
New deals every morning. By email on Mondays.
All deals of the previous week in one email, with source and adviser.